CEO of Invisalign Braces Maker Is Confident in China
*By Conor White*
With the company's first manufacturing plant in China up and running, the chief executive of Align Technology, the maker of Invisalign orthodontics, isn't concerned about a possible trade war between the United States and China.
"By the end of the year we'll have a good, contained business in China, and be able to service our Chinese business," said Joe Hogan, the CEO of Align Technology. "So I feel great about the moves we've made there, given the talks that are going on."
Align's stock was the top performer on the S&P 500 in the last year, soaring 132 percent in 2017. The company's management has said sales could top $2 billion by 2020.
To reach that goal, the company is reaching out directly to consumers who may need its Invisalign products: clear, plastic teeth aligners taking the place of traditional metal braces.
"We have a really strong consumer business, in the sense that we advertise to consumers, and direct them toward doctors," Hogan said in an interview Tuesday with Cheddar. "So the consumer awareness part of this is a big part of this strategy also."
Consumers are increasingly aware: Invisalign shipments are up more than 30 percent year-over-year in the first quarter of this year.
For the full interview, [click here](https://cheddar.com/videos/stars-align-for-invisalign).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
